News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
3p-AseBio-Biotecnologia.
The Regional Minister for Economic and Business Development Mikel Irujo meets with the management of 3P Biopharmaceuticals and its majority shareholder Keensight Capital
Access to innovation · Corporate
During the meeting, attendees evaluated 3P's trajectory and its investment plan for the next 5…
Partners - 3PBIOVIAN
Pacto climático Comisión Europea Asebio MNCN Biodiversidad
European Climate Pact shows 100 students how science is protecting the planet
Climate change
AseBio and the National Museum of Natural Sciences are collaborating again to bring biotechnology…
Intein Splicing
Canadian Intelectual Property Office (CIPO) has conceded ZIP Solutions “Split Inteins and uses thereof” patent.
Healthcare · Access to innovation · In vitro diagnostics · Drug discovery · Rare diseases · Innovative drugs · Personalized medicine · Advanced therapies · Gene editing · International
The tool has many biotech applications
Partners - Biotechnology Assets
genesis-AseBio-Biotecnologia
The spin-off RetinaReadRisk has been created for marketing software and a mobile system based on artificial intelligence to detect diabetic retinopathy in the early stages
Access to innovation
The creation of the company has been carried out within the framework of a project supported by EIT…
Partners - GENESIS Biomed
Firma cátedra Peaches UAM
Peaches Biotech, Universidad Autónoma of Madrid and its Foundation create the first University Chair in Advanced Therapies based on cell secretomes
Healthcare · Innovative drugs · Personalized medicine · Advanced therapies
The UAM-Peaches Chair will promote research and teaching in the areas of Cellular Therapy and…
Partners - PEACHES BIOTECH S.L.
Oryzon-AseBio-Biotecnologia
ORYZON announces First Patient In in FRIDA, a Phase Ib trial with iadademstat in relapsed/refractory FLT3- mutant acute myeloid leukemia patients
Healthcare · Access to innovation
 Primary objectives: to assess safety, tolerability and RP2D
Partners - Oryzon Genomics
GeniosYTalentos-AseBio-Biotecnologia
#NewMember | "AseBio is the Ágora from which to connect with other people and companies in the Biotechnology sector"
Access to innovation
Meet Genios y Talentos, our new member. We talked to Egoitz Calvo Gracia,…
Oryzon-AseBio-Biotecnologia
ORYZON announces clinical candidate nomination of ORY-4001 for the treatment of CNS disorders
Healthcare · Access to innovation · Corporate
Rescues motor-neuronal deficiencies in a Charcot-Marie-Tooth model
Partners - Oryzon Genomics
Teresa riesgo mujeres biotech asebio
AseBio presents first study on female participation in biotechnology industry
Services · Talento
The event was attended by Teresa Riesgo, Secretary General for Innovation, and Ana Polanco,…